Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

A woman who waited for four years on an NHS waiting list for weight-loss support has said she believes she could have avoided ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Concerns around those who are a healthy weight obtaining injections privately, as well as distribution of fake pens ...

GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...

Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.